Articles

First Drug Treatment for Peanut Allergy Receives FDA Approval

February 03, 2020

Officials with the FDA have approved Aimmune Therapeutics’ Peanut (Arachis hypogaea) Allergen Powder-dnfp (Palforzia) to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.

FDA Expands Topical Treatment Options for Adolescents with Plaque Psoriasis

July 31, 2019

Officials with the FDA have taken action on LEO Pharma’s calcipotriene and betamethasone dipropionate foam and topical suspension products for the topical treatment of plaque psoriasis in patients age 12 years and older.